An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter

被引:306
|
作者
Cleutjens, KBJM
vanderKorput, HAGM
vanEekelen, CCEM
vanRooij, HCJ
Faber, PW
Trapman, J
机构
关键词
D O I
10.1210/me.11.2.148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prostate-specific antigen (PSA) is expressed at a high level in the luminal epithelial cells of the prostate and is absent or expressed at very low levels in other tissues. PSA expression can be regulated by androgens. Previously, two functional androgen-response elements were identified in the proximal promoter of the PsA gene. To detect additional, more distal control elements, DNaseI-hypersensitive sites (DHSs) upstream of the PSA gene were mapped in chromatin from the prostate-derived cell line LNCaP grown in the presence and absence of the synthetic androgen R1881. In a region 4.8 to 3.8 kb upstream of the transcription start site of the PSA gene, a cluster of three DHSs was detected. The middle DNAseI-hypersensitive site (DHSII, at similar to-4.2 kb) showed strong androgen responsiveness in LNCaP cells and was absent in chromatin from HeLa cells. Further analysis of the region encompassing DHSII provided evidence for the presence of a complex, androgen-responsive and cell-specific enhancer. In transient transfected LNCaP cells, PSA promoter constructs containing this upstream enhancer region showed approximately 3000-fold higher activity in the presence than in the absence of R1881. The core region of the enhancer could be mapped within a 440-bp fragment. The enhancer showed synergistic cooperation with the proximal PsA promoter and was found to be composed of at least three separate regulatory regions. In the center, a functionally active, high-affinity androgen receptor binding site (GGAACATATTGTATC) could be identified. Mutation of this element almost completely abolished PSA promoter activity. Transfection experiments in prostate and nonprostate cell lines showed largely LNCaP cell specificity of the upstream enhancer region, although some activity was found in the T47D mammary tumor cell line.
引用
收藏
页码:148 / 161
页数:14
相关论文
共 50 条
  • [21] Recombinant adenovirus mediated prostate-specific enzyme ProDrug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter
    Zeng, Hao
    Wei, Qiang
    Huang, Rui
    Chen, Ni
    Dong, Qiang
    Yang, Yuru
    Zhou, Qiao
    JOURNAL OF ANDROLOGY, 2007, 28 (06): : 827 - 835
  • [22] Construction and In Vitro Evaluation of Tissue-Specific Prostate-Specific Antigen Promoter/Enhancer-Regulated Vectors
    Shen, Junkang
    Wang, Lihui
    Zhao, Wenlu
    Wei, Chaogang
    Xiao, Li
    Yang, Yi
    Li, Kai
    SCIENCE OF ADVANCED MATERIALS, 2014, 6 (04) : 803 - 807
  • [23] Gene silencing in androgen-responsive prostate cancer cells from the tissue-specific Prostate-Specific antigen promoter
    Song, J
    Pang, S
    Lu, YC
    Yokoyama, KK
    Zheng, JY
    Chiu, R
    CANCER RESEARCH, 2004, 64 (21) : 7661 - 7663
  • [24] Re: Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection Response
    Haines, Ian E.
    Miklos, George L. Gabor
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02):
  • [25] Prostate-specific antigen doubling time predicts response to deferred anti-androgen therapy in men with androgen-independent prostate cancer
    Shulman, MJ
    Karam, JA
    Benaim, EA
    UROLOGY, 2004, 63 (04) : 732 - 736
  • [26] A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer
    He, WW
    Sciavolino, PJ
    Wing, J
    Augustus, M
    Hudson, P
    Meissner, PS
    Curtis, RT
    Shell, BK
    Bostwick, DG
    Tindall, DJ
    Gelmann, EP
    AbateShen, C
    Carter, KC
    GENOMICS, 1997, 43 (01) : 69 - 77
  • [27] Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer
    Gotoh, A
    Ko, SC
    Shirakawa, T
    Cheon, J
    Kao, CH
    Miyamoto, T
    Gardner, TA
    Ho, LJ
    Cleutjens, CBJ
    Trapman, J
    Graham, FL
    Chung, LWK
    JOURNAL OF UROLOGY, 1998, 160 (01): : 220 - 229
  • [28] Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells
    Yeung, F
    Li, XY
    Ellett, J
    Trapman, J
    Kao, CH
    Chung, LWK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) : 40846 - 40855
  • [29] PART-1:: A novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12
    Lin, BY
    White, JT
    Ferguson, C
    Bumgarner, R
    Friedman, C
    Trask, B
    Ellis, W
    Lange, P
    Hood, L
    Nelson, PS
    CANCER RESEARCH, 2000, 60 (04) : 858 - 863
  • [30] Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre recombinase/LoxP system for prostate cancer cells under androgen ablation condition
    Ikegami, S
    Tadakuma, T
    Suzuki, S
    Yoshimura, I
    Asano, T
    Hayakawa, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (10): : 1154 - 1163